Skip to main content
MIMEDX GROUP, INC. logo

MIMEDX GROUP, INC. — Investor Relations & Filings

Ticker · MDXG ISIN · US6024961012 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2026-04-29 Annual Report
Country US United States of America
Listing US MDXG

About MIMEDX GROUP, INC.

https://mimedx.com/

MIMEDX GROUP, INC. is a biopharmaceutical company specializing in placental biologics. As a pioneer in the field, the company develops and distributes human placental tissue allografts using proprietary, patent-protected processes. These therapeutic products are designed for applications in advanced wound care, surgical procedures, and burn treatment. MIMEDX's portfolio is supported by extensive scientific and clinical evidence, aiming to provide innovative solutions that elevate the standard of care for patients and healthcare professionals. The company also focuses on ensuring broad patient access to its therapies through comprehensive payer insurance coverage.

Recent filings

Filing Released Lang Actions
ARS - MIMEDX GROUP, INC. (0001376339) (Filer)
Annual Report FY 2025
2026-04-29 English
8-K - MIMEDX GROUP, INC. (0001376339) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 14, 2026. It reports the departure of a Chief Operating Officer and salary reductions for executive officers as part of a cost reduction initiative. The document includes a press release as an exhibit. The content focuses on management changes and executive compensation adjustments, which aligns with announcements about changes in senior management or board members. The document length is 4278 characters, which is relatively short and typical for an 8-K reporting management changes. There is no detailed financial data or comprehensive report content, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy statement or voting results announcement. Therefore, the best classification is Board/Management Information (MANG).
2026-04-16 English
4 - MIMEDX GROUP, INC. (0001376339) (Issuer)
Director's Dealing
2026-03-17 English
4 - MIMEDX GROUP, INC. (0001376339) (Issuer)
Director's Dealing
2026-03-17 English
8-K - MIMEDX GROUP, INC. (0001376339) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or updates by a company. The text specifically mentions the issuance of an Earnings Press Release for the fourth quarter and full year ended December 31, 2025, and the scheduling of an Earnings Call and updated Investor Presentation. The document includes references to these materials as exhibits but does not itself contain detailed financial statements or comprehensive financial analysis. The primary purpose is to announce the earnings release and related events rather than to present the full earnings report or detailed financial data. Therefore, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only.
2026-02-25 English
10-K - MIMEDX GROUP, INC. (0001376339) (Filer)
Annual Report FY 2025
2026-02-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.